Act Quickly On Converted EU Product Approvals, GB Firms Urged
Companies Can Opt Out Of “Grandfathering” Process
Executive Summary
The UK medicines regulator has written to pharmaceutical companies outlining the actions they need to take regarding products with a centralized EU approval that will be converted to Great Britain marketing authorizations next year.